Arlene Siefker-Radtke, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Mirati
    Topic:
    Consultant/Honorarium Event
    Date added:
    05/11/2023
    Date updated:
    07/03/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Nektar Therapeutics
    Topic:
    Consultant/Honorarium Event
    Date added:
    05/11/2023
    Date updated:
    07/03/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Seattle Genetics
    Topic:
    Consultant/Honorarium Event
    Date added:
    05/11/2023
    Date updated:
    07/03/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Taiho
    Topic:
    Consultant/Honorarium Event
    Date added:
    05/11/2023
    Date updated:
    07/03/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Basilea Pharmaceutica
    Topic:
    Clinical Grant to Institution
    Date added:
    05/11/2023
    Date updated:
    07/03/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Bristol Myers Squibb
    Topic:
    Clinical Grant to Institution
    Date added:
    05/11/2023
    Date updated:
    07/03/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Janssen
    Topic:
    Clinical Grant to Institution
    Date added:
    05/11/2023
    Date updated:
    07/03/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merck
    Topic:
    Clinical Grant to Institution
    Date added:
    05/11/2023
    Date updated:
    07/03/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Millennium
    Topic:
    Clinical Grant to Institution
    Date added:
    05/11/2023
    Date updated:
    07/03/2024
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Nektar Therapeutics
    Topic:
    Clinical Grant to Institution
    Date added:
    05/11/2023
    Date updated:
    07/03/2024

Pages

Return to 2023 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes